Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension

Steeve Provencher; Patrap Paruchuru; Andrea Spezzi; Brian Waterhouse; Mardi Gomberg-Maitland; on behalf of the pH12 Flolan reformulation study group

doi:10.1371/journal.pone.0120657

Loading metrics

Open Access

Peer-reviewed

Research Article

Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension

Steeve Provencher ,

Contributed equally to this work with: Steeve Provencher, Patrap Paruchuru, Andrea Spezzi, Brian Waterhouse, Mardi Gomberg-Maitland

* E-mail: Steve.provencher@criucpq.ulaval.ca

Affiliation Pulmonary Hypertension Research Group, Centre de recherche de l’Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Québec, Canada
⨯
Patrap Paruchuru ,

Contributed equally to this work with: Steeve Provencher, Patrap Paruchuru, Andrea Spezzi, Brian Waterhouse, Mardi Gomberg-Maitland

Affiliation GlaxoSmithKline R&D, 980 Great West Road, Brentford, United Kingdom
⨯
Andrea Spezzi ,

Contributed equally to this work with: Steeve Provencher, Patrap Paruchuru, Andrea Spezzi, Brian Waterhouse, Mardi Gomberg-Maitland

Affiliation GlaxoSmithKline R&D, 980 Great West Road, Brentford, United Kingdom
⨯
Brian Waterhouse ,

Contributed equally to this work with: Steeve Provencher, Patrap Paruchuru, Andrea Spezzi, Brian Waterhouse, Mardi Gomberg-Maitland

Affiliation GlaxoSmithKline R&D, 980 Great West Road, Brentford, United Kingdom
⨯
Mardi Gomberg-Maitland ,

Contributed equally to this work with: Steeve Provencher, Patrap Paruchuru, Andrea Spezzi, Brian Waterhouse, Mardi Gomberg-Maitland

Affiliation University of Chicago Medical Centre, 5841 S Maryland Ave, MC5403, Rm L08, Chicago, Illinois, United States of America
⨯
on behalf of the pH12 Flolan reformulation study group

¶Membership of the pH12 Flolan reformulation study group is provided in the Acknowledgments.
⨯

Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension

Steeve Provencher,
Patrap Paruchuru,
Andrea Spezzi,
Brian Waterhouse,
Mardi Gomberg-Maitland,
on behalf of the pH12 Flolan reformulation study group

Published: March 20, 2015
https://doi.org/10.1371/journal.pone.0120657

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Questionnaires
Is the Subject Area "Questionnaires" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Hemodynamics
Is the Subject Area "Hemodynamics" applicable to this article?

Thanks for your feedback.
Quality of life
Is the Subject Area "Quality of life" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Pulmonary arteries
Is the Subject Area "Pulmonary arteries" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Diluents
Is the Subject Area "Diluents" applicable to this article?

Thanks for your feedback.